Processa Pharmaceuticals, Inc. Sales Revenue, Services, Net (Deprecated 2018-01-31)
Processa Pharmaceuticals, Inc. (PCSA) reported Sales Revenue, Services, Net (Deprecated 2018-01-31) of $28.87 thousand for the 9-month period ending 2015-09-30, per its 10-Q filed 2015-12-01.
Discontinued › Expense Statement › Operating Expenses
us-gaap:SalesRevenueServicesNet · last filed 2015-12-01
- Processa Pharmaceuticals, Inc. sales revenue, services, net (deprecated 2018-01-31) for the quarter ending 2015-09-30 was $0.00, a 100.00% decline year-over-year.
- Processa Pharmaceuticals, Inc. sales revenue, services, net (deprecated 2018-01-31) for the quarter ending 2015-06-30 was $20.04K, a 35.30% decline year-over-year.
- Processa Pharmaceuticals, Inc. sales revenue, services, net (deprecated 2018-01-31) for the quarter ending 2015-03-31 was $8.83K, a 31.55% decline year-over-year.
- Processa Pharmaceuticals, Inc. sales revenue, services, net (deprecated 2018-01-31) for the quarter ending 2014-12-31 was $13.09K.
- Processa Pharmaceuticals, Inc. sales revenue, services, net (deprecated 2018-01-31) for fiscal 2014 was $92.96K, a 271.85% increase from fiscal 2013.
- Processa Pharmaceuticals, Inc. sales revenue, services, net (deprecated 2018-01-31) for fiscal 2013 was $25.00K.
| Period end | Sales Revenue, Services, Net (Deprecated 2018-01-31) 3 month | Sales Revenue, Services, Net (Deprecated 2018-01-31) 6 month | Sales Revenue, Services, Net (Deprecated 2018-01-31) 9 month | Sales Revenue, Services, Net (Deprecated 2018-01-31) 12 month | Sales Revenue, Services, Net (Deprecated 2018-01-31) 36 month |
|---|---|---|---|---|---|
| 2015-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2015-12-01 | $20.04K derived: sum of 2 quarters · filed 2015-12-01 | $28.87K 10-Q · filed 2015-12-01 | $41.96K derived: sum of 4 quarters · filed 2015-12-01 | |
| 2015-06-30 | $20.04K 10-Q · filed 2015-08-19 | $28.87K 10-Q · filed 2015-08-19 | $41.96K derived: sum of 3 quarters · filed 2015-08-19 | $77.96K derived: sum of 4 quarters · filed 2015-12-01 | |
| 2015-03-31 | $8.83K 10-Q · filed 2015-05-15 | $21.92K derived: sum of 2 quarters · filed 2015-05-15 | $57.92K derived: sum of 3 quarters · filed 2015-12-01 | $88.89K derived: sum of 4 quarters · filed 2015-12-01 | |
| 2014-12-31 | $13.09K derived: 10-K 12 month − 10-Q 9 month · filed 2015-04-14 | $49.09K derived: sum of 2 quarters · filed 2015-12-01 | $80.06K derived: sum of 3 quarters · filed 2015-12-01 | $92.96K 10-K · filed 2015-04-14 | |
| 2014-09-30 | $36.00K 10-Q · filed 2015-12-01 | $66.97K derived: sum of 2 quarters · filed 2015-12-01 | $79.87K 10-Q · filed 2015-12-01 | ||
| 2014-06-30 | $30.98K 10-Q · filed 2015-08-19 | $43.88K 10-Q · filed 2015-08-19 | |||
| 2014-03-31 | $12.90K 10-Q · filed 2015-05-15 | $37.90K 10-Q · filed 2014-05-14 | |||
| 2013-12-31 | $25.00K 10-K · filed 2015-04-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| AMARIN CORP PLC\UK (AMRN) | $0.005B | -247.24 | |
| Xenetic Biosciences, Inc. (XBIO) | United States | $0.006B | |
| ProPhase Labs, Inc. (PRPH) | United States | $0.006B | -0.06 |
| Dermata Therapeutics, Inc. (DRMA) | United States | $0.005B | -0.62 |
| REVIVA PHARMACEUTICALS HOLDINGS, INC. (RVPH) | United States | $0.005B | |
| Cadrenal Therapeutics, Inc. (CVKD) | United States | $0.004B | -0.90 |
| Pulmatrix, Inc. (PULM) | United States | $0.006B | |
| Lakewood-Amedex Biotherapeutics Inc. (LABT) | United States | $0.004B | |
| Ernexa Therapeutics Inc. (ERNA) | United States | $0.006B | |
| 60 DEGREES PHARMACEUTICALS, INC. (SXTP) | United States | $0.004B | -0.59 |